Amorphical
Amorphous Calcium Carbonate Products
StartupAmorphical is a Ness Ziona-based startup in the Health Tech & Life Sciences sector, established in 2004. Amorphous Calcium Carbonate Products. The company has raised a total of $28.3M across 6 funding rounds, currently at the F stage. Amorphical was founded by Yossi Ben. Key investors include ICU group, Undisclosed Investor(s). The company has 11-50 employees. Core technologies: Materials & Substances.
With $28.3M in total funding, Amorphical is a F-stage company operating in Health Tech & Life Sciences. The company follows a B2B/B2B2C business model. Product stage: Released. The company holds 1 patent.
- StageF
- ProductReleased
- ModelB2B, B2B2C
- Employees11-50
- HQNess Ziona
- DistrictCenter District
- Last Round$6M
- ICU group
- Undisclosed Investor(s)
Yossi BenFounder & Chairman
7 articles covered by sources including www.prnewswire.com,
www.israelhayom.com,
newsdirect.com,
www.calcalist.co.il,
www.globes.co.il.
What does Amorphical do?
Amorphical is a pioneering biotechnology company that develops and manufactures unique natural-based medicines and dietary supplements with high bio-availability, aiming at the improvement of calcium absorption and management, in tandem with balancing the body's acidity level (pH) derived by various biomedical conditions. These features are critical for maintaining health, repairing bone deficiencies, treating severe diseases, and aiding the development and strengthening of the body. Amorphical’s leading scientists succeeded in stabilizing and preserving a rare natural form of calcium used by blue crayfish to develop a unique nanometric substance called amorphous calcium carbonate, which helps improve people's health and quality of life.
How much funding has Amorphical raised?
Amorphical has raised $28.3M in total funding across 6 rounds. The company is currently at the F stage. Key investors include ICU group, Undisclosed Investor(s).
Who founded Amorphical?
Amorphical was founded in 2004 by Yossi Ben (Founder & Chairman).
What sector is Amorphical in?
Amorphical operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Materials & Substances. Target customers: Industrial Manufacturing, Discrete Industries, Aerospace, Healthcare & Life Sciences, Life Sciences, Pharmaceuticals, Biotechnology, Healthcare, Patients.
Where is Amorphical located?
Amorphical is based in HaHarash Street 11, Nes Ziyyona, Israel, Center District.